New Diabetes Drug Approved

The FDA has approved albiglutide (Tanzeum) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.

The drug, which is a glucagon-like peptide-1 (GLP-1), was studied in 8 clinical trials that involved more than 2,000 type 2 diabetes patients. In all trials, patients demonstrated an improvement in glycated hemoglobin (HbA1c) levels.


Read the source article at Renal & Urology News

About the Author

Leave a Reply